Depreciation of Anika Therapeutics, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Anika Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Anika Therapeutics, Inc. Depreciation for the quarter ending 31 Dec 2025 was $1,500,000, a 15% increase year-over-year.
  • Anika Therapeutics, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $5,400,000, a 8% increase year-over-year.
  • Anika Therapeutics, Inc. annual Depreciation for 2025 was $5,400,000, a 8% increase from 2024.
  • Anika Therapeutics, Inc. annual Depreciation for 2024 was $5,000,000, a 2% increase from 2023.
  • Anika Therapeutics, Inc. annual Depreciation for 2023 was $4,900,000, unchanged from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Anika Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $5,400,000 $1,500,000 +$200,000 +15% 01 Oct 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 $5,200,000 $1,400,000 +$100,000 +7.7% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $5,100,000 $1,300,000 +$100,000 +8.3% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $5,000,000 $1,200,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $5,000,000 $1,300,000 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 $1,300,000 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $1,200,000 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025 2025 Q2
Q1 2024 $1,200,000 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1

Anika Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $5,400,000 +$400,000 +8% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $5,000,000 +$100,000 +2% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $4,900,000 $0 0% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2026 2025 FY
2022 $4,900,000 -$1,600,000 -25% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025 2024 FY
2021 $6,500,000 +$400,000 +6.6% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2024 2023 FY
2020 $6,100,000 +$1,100,000 +22% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2023 2022 FY
2019 $5,000,000 +$100,000 +2% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2022 2021 FY
2018 $4,900,000 +$1,600,000 +48% 01 Jan 2018 31 Dec 2018 10-K/A 26 Apr 2021 2020 FY
2017 $3,300,000 +$600,000 +22% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2020 2019 FY
2016 $2,700,000 $0 0% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $2,700,000 +$100,000 +3.8% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $2,600,000 -$100,000 -3.7% 01 Jan 2014 31 Dec 2014 10-K 24 Feb 2017 2016 FY
2013 $2,700,000 +$203,251 +8.1% 01 Jan 2013 31 Dec 2013 10-K 10 Mar 2016 2015 FY
2012 $2,496,749 +$680,561 +37% 01 Jan 2012 31 Dec 2012 10-K 13 Mar 2015 2014 FY
2011 $1,816,188 +$507,475 +39% 01 Jan 2011 31 Dec 2011 10-K 13 Mar 2014 2013 FY
2010 $1,308,713 01 Jan 2010 31 Dec 2010 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.